Employing Bayesian Approach to the Intermediate Risk Categories of the Bethesda Thyroid Cytopathology Reporting System: Can FDG PET/CT Find a Strong Enough Evidence-base to Be Practised Clinically As an Adjunct?

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2014 Sep 10

PMID 25201009

Citations 1

Authors

Sandip Basu

Affiliations

Soon will be listed here.

Citing Articles

Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System.

Basu S, Mahajan A, Arya S World J Nucl Med. 2016; 15(2):130-3.

PMID: 27134564 PMC: 4809154. DOI: 10.4103/1450-1147.176883.

References

Morbelli S, Bagnasco M . Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?. Eur J Nucl Med Mol Imaging. 2014; 41(8):1479-81. DOI: 10.1007/s00259-014-2794-7. View

Gavriel H, Tang A, Eviatar E, Chan S . Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients. Eur Arch Otorhinolaryngol. 2014; 272(7):1763-8. DOI: 10.1007/s00405-014-3120-5. View

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F . ¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2014; 41(8):1482-91. DOI: 10.1007/s00259-014-2774-y. View

Nayan S, Ramakrishna J, Gupta M . The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2014; 151(2):190-200. DOI: 10.1177/0194599814530861. View

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View